
Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma
Author(s) -
Kazuhiro Kasai,
Akira Ushio,
Yukiho Kasai,
Kei Sawara,
Yukio Miyamoto,
Kaori Oikawa,
Yasuhiro Takikawa,
Kazuyuki Suzuki
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i14.2242
Subject(s) - lipiodol , hepatocellular carcinoma , medicine , clinical endpoint , gastroenterology , response evaluation criteria in solid tumors , carcinoma , adverse effect , cisplatin , overall survival , survival rate , urology , surgery , chemotherapy , clinical trial , phases of clinical research
To evaluate the efficacy of transarterial chemoembolization (TACE) using a suspension of a fine-powder formulation of cisplatin (DDPH) in lipiodol (LPD) in the treatment of hepatocellular carcinoma (HCC).